View of SURVIVAL OUTCOMES AND RELATED FACTORS IN FIRST-LINE OSIMERTINIB TREATMENT FOR ADVANCED EGFR-MUTATED NON-SMALL CELL LUNG CANCER

Return to Article Details SURVIVAL OUTCOMES AND RELATED FACTORS IN FIRST-LINE OSIMERTINIB TREATMENT FOR ADVANCED EGFR-MUTATED NON-SMALL CELL LUNG CANCER Download Download PDF